Evolution of therapy for cystic fibrosis
- PMID: 8052279
- DOI: 10.1056/NEJM199409083311011
Evolution of therapy for cystic fibrosis
Comment on
-
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.N Engl J Med. 1994 Sep 8;331(10):637-42. doi: 10.1056/NEJM199409083311003. N Engl J Med. 1994. PMID: 7503821 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical